Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAND: Facebook Intervention for Smoking and Heavy Drinking
NCT03163303Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Dec 2017
- Primary completion
- Jun 2019
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Tobacco Use Disorder (TUD) (2 arms), sponsored by University of California, San Francisco. Primary endpoints: 7-day Point Prevalence Abstinence at 3 Months, 7-day Point Prevalence Abstinence at 6 Months and 1 more. Started Dec 2017; status: completed.
02
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT03163303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03163303.